India EPI Diagnosis and Therapeutics Market to 2032

Overview

The India EPI Diagnosis and Therapeutics Market is expected to reach a 285.06 USD Million by 2032 and is projected to grow at a CAGR of 11.38% from 2025 to 2032.

Revenue, 2024 (USD Million)
155.86
Forecast, 2032 (USD Million)
285.06
CAGR, 2024 - 2032
11.38%
Report Coverage
India

India EPI Diagnosis and Therapeutics Market 2018-2032 USD Million

India EPI Diagnosis and Therapeutics Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 155.86 USD Million
  • Projected Market Size (2032): 285.06 USD Million
  • CAGR (2025-2032): 11.38%

Key Findings of India EPI Diagnosis and Therapeutics Market

  • The India EPI Diagnosis and Therapeutics Market was valued at 285.06 USD Million in 2024.
  • The India EPI Diagnosis and Therapeutics Market is likely to grow at a CAGR of 11.38% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Branded in Drug Segment accounted for the largest share of the market with a revenue of 147.33 USD Million
  • The fastest growing segment Branded in Drug Segment grew Fastest with a CAGR of 14.79% during the forecast period from 2024 to 2032.

India EPI Diagnosis and Therapeutics Market Scope

India EPI Diagnosis and Therapeutics Market Segmentation & Scope
Type
  • Diagnosis
  • Treatment
Distribution Channel
  • Others
  • Third Party Distributors
  • Retail Pharmacy
  • Direct Tender
End User
  • Others
  • Research and Academic Institutes
  • Homecare
  • Diagnostic Center
  • Specialty Clinics
  • Hospitals
Drug
  • Generic
  • Branded

India EPI Diagnosis and Therapeutics Market Data Coverage Insights

Study Period 2024-2032
Base Year 2021
Unit Revenue in USD Million
Market Value in 2024 155.86 USD Million
Market Value in 2032 285.06 USD Million
CAGR (2025-2032) 11.38%
Historic Data 2016-2023
Market Segments Covered Type,Distribution Channel,End User,Drug

Regional Insights:

  • Leading Market (2024-2032): India, leading in terms of revenue 155.86 USD Million in 2024
    • Key Country: India, leading in terms of revenue with value of 155.86 USD Million in 2024.

Segments and Scope

  • India EPI Diagnosis and Therapeutics Market to 2032, By Type
    • Treatment is the largest segment in India EPI Diagnosis and Therapeutics Market to 2032 with a revenue of 89.66 USD Million in the year 2024.
    • Treatment is the Fastest growing segment in India EPI Diagnosis and Therapeutics Market to 2032 with a Growth rate of 12.44 % in forecast period 2025-2032.
  • India EPI Diagnosis and Therapeutics Market to 2032, By Distribution Channel
    • Direct Tender is the largest segment in India EPI Diagnosis and Therapeutics Market to 2032 with a revenue of 102.25 USD Million in the year 2024.
    • Direct Tender is the Fastest growing segment in India EPI Diagnosis and Therapeutics Market to 2032 with a Growth rate of 12.33 % in forecast period 2025-2032.
  • India EPI Diagnosis and Therapeutics Market to 2032, By End User
    • Hospitals is the largest segment in India EPI Diagnosis and Therapeutics Market to 2032 with a revenue of 57.45 USD Million in the year 2024.
    • Hospitals is the Fastest growing segment in India EPI Diagnosis and Therapeutics Market to 2032 with a Growth rate of 13.71 % in forecast period 2025-2032.
  • India EPI Diagnosis and Therapeutics Market to 2032, By Drug
    • Branded is the largest segment in India EPI Diagnosis and Therapeutics Market to 2032 with a revenue of 147.33 USD Million in the year 2024.
    • Branded is the Fastest growing segment in India EPI Diagnosis and Therapeutics Market to 2032 with a Growth rate of 14.79 % in forecast period 2025-2032.

India EPI Diagnosis and Therapeutics Market Company Share Analysis

 
Company Name Company Share Analysis
Nestlé
Janssen Global Services, LLC
Laboratory Corporation of America Holdings
VIVUS LLC.
Alcresta Therapeutics, Inc.
India EPI Diagnosis and Therapeutics Market Company Share Analysis

India EPI Diagnosis and Therapeutics Market Geographical Sales Distribution, 2018-2032 USD Million

India EPI Diagnosis and Therapeutics Market Geographical Sales Distribution, 2018-2032 USD Million

India EPI Diagnosis and Therapeutics Market Company Profiling

India EPI Diagnosis and Therapeutics Market Company Profiling
Frequently Asked Questions
The India EPI Diagnosis and Therapeutics Market is segmented based on Segmentation Type,Distribution Channel,End User,Drug.
India EPI Diagnosis and Therapeutics Market was valued at USD 155.86(Revenue in USD Million) in 2021.
India EPI Diagnosis and Therapeutics Market is projected to grow at a CAGR of 11.38% during the forecast period of 2024 to 2032.
The Branded segment is expected to dominate the India EPI Diagnosis and Therapeutics Market, holding a largest market share of 147.33 USD Million in 2024

Coming Soon....

India EPI Diagnosis and Therapeutics Market Scope

India EPI Diagnosis and Therapeutics Market Segmentation & Scope
Type
  • Diagnosis
  • Treatment
Distribution Channel
  • Others
  • Third Party Distributors
  • Retail Pharmacy
  • Direct Tender
End User
  • Others
  • Research and Academic Institutes
  • Homecare
  • Diagnostic Center
  • Specialty Clinics
  • Hospitals
Drug
  • Generic
  • Branded
Frequently Asked Questions
The India EPI Diagnosis and Therapeutics Market is segmented based on Segmentation Type,Distribution Channel,End User,Drug.
India EPI Diagnosis and Therapeutics Market was valued at USD 155.86(Revenue in USD Million) in 2021.
India EPI Diagnosis and Therapeutics Market is projected to grow at a CAGR of 11.38% during the forecast period of 2024 to 2032.
The estimated market value of the India EPI Diagnosis and Therapeutics Market for final year is USD 285.06 (USD Million).

India EPI Diagnosis and Therapeutics Market Company Profiling

India EPI Diagnosis and Therapeutics Market Company Profiling
Frequently Asked Questions
The India EPI Diagnosis and Therapeutics Market is segmented based on Segmentation Type,Distribution Channel,End User,Drug.
India EPI Diagnosis and Therapeutics Market was valued at USD 155.86(Revenue in USD Million) in 2021.
India EPI Diagnosis and Therapeutics Market is projected to grow at a CAGR of 11.38% during the forecast period of 2024 to 2032.
The estimated market value of the India EPI Diagnosis and Therapeutics Market for final year is USD 285.06 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.